Literature DB >> 20817104

Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis.

I Pirko1, A J Johnson, Yi Chen, D M Lindquist, A K Lohrey, J Ying, R Scott Dunn.   

Abstract

White matter (WM) lesions are the classic pathological hallmarks of multiple sclerosis (MS). However, MRI-based WM lesion load shows relatively poor correlation with functional outcome, resulting in the "clinico-radiological paradox" of MS. Unlike lesion based measures, volumetric MRI assessment of brain atrophy shows a strong correlation with functional outcome, and the presence of early atrophy predicts a worse disease course. While extensive literature exists describing MRI characteristics of atrophy in MS, the exact pathogenesis and the substrate of atrophy-gray vs. WM loss, axonal/neuronal damage vs. demyelination, or a combination of the above-remain unclear. Animal models of atrophy would allow for detailed investigations of the pathomechanism, and would contribute to an enhanced understanding of structural-functional connections in this complex disease. We now report that in the Theiler's Murine Encephalitis Virus (TMEV) model of MS in SJL/J mice, significant brain atrophy accompanies the development of the progressive MS-like disease. We conducted volumetric MRI studies in 8 cases and 4 age, gender- and strain-matched control mice. While in controls we did not detect any brain atrophy, significant atrophy developed as early as 3 months into the disease course, and reached its peak by 6 months, resulting in ventricular enlargement by 118% (p=0.00003). A strong correlation (r=-0.88) between atrophy and disability, as assessed by rotarod assay, was also demonstrated. We earlier reported another neurodegenerative feature in this model, the presence of deep gray matter T2 hypointensity in thalamic nuclei. Future studies utilizing this model will allow us to investigate key components of MRI detectable neurodegenerative feature development, their tissue correlations and associations with functional outcome measures. These studies are expected to pave the way to a better understanding of the substrate of disability in MS models.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20817104      PMCID: PMC3858208          DOI: 10.1016/j.neuroimage.2010.08.055

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  25 in total

Review 1.  3-D visualization in biomedical applications.

Authors:  R A Robb
Journal:  Annu Rev Biomed Eng       Date:  1999       Impact factor: 9.590

Review 2.  The clinico-radiological paradox in multiple sclerosis revisited.

Authors:  Frederik Barkhof
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

3.  Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.

Authors:  Nynke F Kalkers; Najim Ameziane; Joost C J Bot; Arjan Minneboo; Chris H Polman; Frederik Barkhof
Journal:  Arch Neurol       Date:  2002-10

4.  Contrasting murine models of MS.

Authors:  A L A Nelson; A J Bieber; M Rodriguez
Journal:  Int MS J       Date:  2004-12

Review 5.  Clinical-magnetic resonance imaging correlations in multiple sclerosis.

Authors:  Robert Zivadinov; Thomas P Leist
Journal:  J Neuroimaging       Date:  2005       Impact factor: 2.486

6.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

Authors:  Ralph H B Benedict; Bianca Weinstock-Guttman; Inna Fishman; Jitendra Sharma; Christopher W Tjoa; Rohit Bakshi
Journal:  Arch Neurol       Date:  2004-02

7.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

8.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

9.  Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis.

Authors:  C M Dalton; P A Brex; R Jenkins; N C Fox; K A Miszkiel; W R Crum; J I O'Riordan; G T Plant; A J Thompson; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

Review 10.  Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination.

Authors:  Ikuo Tsunoda; Robert S Fujinami
Journal:  Springer Semin Immunopathol       Date:  2002
View more
  20 in total

1.  CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support.

Authors:  Holly L Johnson; Yi Chen; Fang Jin; Lisa M Hanson; Jeffrey D Gamez; Istvan Pirko; Aaron J Johnson
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

3.  Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2Db class I molecule.

Authors:  April M Huseby Kelcher; Pascal A Atanga; Jeffrey D Gamez; Luz M Cumba Garcia; Stephanie J Teclaw; Kevin D Pavelko; Slobodan I Macura; Aaron J Johnson
Journal:  FASEB J       Date:  2017-02-10       Impact factor: 5.191

4.  Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis.

Authors:  Nicholas E Martinez; Fridrik Karlsson; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Alireza Minagar; Matthew B Grisham; Ikuo Tsunoda
Journal:  Brain Pathol       Date:  2014-02-25       Impact factor: 6.508

5.  Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis.

Authors:  M Mateo Paz Soldán; Mekala R Raman; Jeffrey D Gamez; Anne K Lohrey; Yi Chen; Istvan Pirko; Aaron J Johnson
Journal:  J Neuroimaging       Date:  2015-04-20       Impact factor: 2.486

6.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

7.  Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol.

Authors:  Jeffrey W Meeusen; Christopher J Klein; Istvan Pirko; Keegan E Haselkorn; Thomas J Kryzer; Sean J Pittock; Daniel H Lachance; P James Dyck; Vanda A Lennon
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

Review 8.  Visualizing iron in multiple sclerosis.

Authors:  Francesca Bagnato; Simon Hametner; Edward Brian Welch
Journal:  Magn Reson Imaging       Date:  2013-01-22       Impact factor: 2.546

9.  CMV infection attenuates the disease course in a murine model of multiple sclerosis.

Authors:  Istvan Pirko; Rhonda Cardin; Yi Chen; Anne K Lohrey; Diana M Lindquist; R Scott Dunn; Robert Zivadinov; Aaron J Johnson
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 10.  Viruses and neurodegeneration.

Authors:  Li Zhou; Monica Miranda-Saksena; Nitin K Saksena
Journal:  Virol J       Date:  2013-05-31       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.